V-ATPase Subunit interactions: The long road to therapeutic targeting

Current Protein and Peptide Science

Volumn 13, Issue 2, 2012, Pages 164-179

  Kartner, Norbert ^a   Manolson, Morris F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone loss pathology; Drug discovery; High throughput screening; Membrane transport; Osteolysis; Osteoporosis; Protein interaction; Tumor metastasis; Vacuolar proton translocating ATPase; Vesicular proton pump

Indexed keywords

3,4 DIHYDROXY N' (2 HYDROXYBENZYLIDENE)BENZOHYDRAZIDE; ADENOSINE TRIPHOSPHATASE (MAGNESIUM); OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN INHIBITOR; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

CELL VACUOLE; DRUG DEVELOPMENT; DRUG SCREENING; DRUG STRUCTURE; HUMAN; MEMBRANE TRANSPORT; METASTASIS; NONHUMAN; OSTEOPOROSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SUBUNIT; REVIEW; SACCHAROMYCES CEREVISIAE; VALIDATION STUDY;

EUKARYOTA; PROKARYOTA;

EID: 84860813774     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/138920312800493179     Document Type: Review

References (152)

1. Toei, M.; Saum, R.; Forgac, M., Regulation and isoform function of the V-ATPases. Biochemistry, 2010, 49, (23), 4715-4723.
2. Sun-Wada, G.-H.; Wada, Y., Vacuolar-type proton pump ATPases: Roles of infunit isoforms in physiology and pathology. Histol. Histopathol., 2010, 25, (12), 1611-1620.
3. Saroussi, S.; Nelson, N., The little we know on the structure and machinery of V-ATPase. J. Exp. Biol., 2009, 212, (11), 1604-1610.
4. +-ATPase in vesicular trafficking: Targeting, regulation and function. Curr. Opin. Cell Biol., 2008, 20, (4), 415-426.
5. +)-ATPases. Arch. Biochem. Biophys., 2008, 476, (1), 33-42.
6. Drory, O.; Nelson, N., The emerging structure of vacuolar ATPases. Physiology, 2006, 21, 317-325.
7. + ATPase: Molecular structure and function, physiological roles and regulation. J. Exp. Biol., 2006, 209, (4), 577-589.
8. +-ATPase a3-B2 infunit interaction. J. Biol. Chem., 2010, 285, (48), 37476-37490.
9. +/ATP coupling ratio. FEBS Lett., 2004, 576, (1-2), 1-4.
10. Muench, S.P.; Trinick, J.; Harrison, M.A., Structural divergence of the rotary ATPases. Q. Rev. Biophys., 2011, 44(3), 311-356.
11. Grüber, G.; Marshansky, V., New insights into structure-function relationships between archeal ATP synthase (A1A0) and vacuolar type ATPase (V1V0). Bioessays, 2008, 30, (11-12), 1096-1109.
12. Imamura, H.; Nakano, M.; Noji, H.; Muneyuki, E.; Ohkuma, S.; Yoshida, M.; Yokoyama, K., Evidence for rotation of V1-ATPase. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, (5), 2312-2315.
13. Yokoyama, K.; Nakano, M.; Imamura, H.; Yoshida, M.; Tamakoshi, M., Rotation of the proteolipid ring in the V-ATPase. J. Biol. Chem., 2003, 278, (27), 24255-24258.
14. + transport to rotary catalysis in F-type ATP synthases: Structure and organization of the transmembrane rotary motor. J. Exp. Biol., 2000, 203, (1), 9-17.
15. +-ATPase infunit genes. Mol. Cell, 2003, 12, (4), 801-803.
16. Miranda, K.C.; Karet, F.E.; Brown, D., An extended nomenclature for mammalian V-ATPase infunit genes and splice variants. PLoS ONE, 2010, 5, (3), e9531.
17. Zhang, Z.; Zheng, Y.; Mazon, H.; Milgrom, E.; Kitagawa, N.; Kish-Trier, E.; Heck, A.J.R.; Kane, P.M.; Wilkens, S., Structure of the yeast vacuolar ATPase. J. Biol. Chem., 2008, 283, (51), 35983-35995.
18. +-translocating adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. A study with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. J. Biol. Chem., 1988, 263, (1), 45-51.
19. Manolson, M.F.; Ouellette, B.F.F.; Filion, M.; Poole, R.J., cDNA sequence and homologies of the 57-kDa nucleotide-binding infunit of the vacuolar ATPase from Arabidopsis. J. Biol. Chem., 1988, 263, (34), 17987-17994.
20. +- translocating tonoplast ATPase. J. Biol. Chem., 1985, 260, (22), 12273-12279.
21. +)-ATPase from bovine brain clathrin-coated vesicles by modification of a rapidly exchangeable, noncatalytic nucleotide binding site on the B infunit. J. Biol. Chem., 1996, 271, (22), 12775-12782.
22. Bowman, B.J.; Allen, R.; Wechser, M.A.; Bowman, E.J., Isolation of genes encoding the Neurospora vacuolar ATPase. Analysis of vma-2 encoding the 57-kDa polypeptide and comparison to vma-1. J. Biol. Chem., 1988, 263, (28), 14002-14007.
23. Maher, M.J.; Akimoto, S.; Iwata, M.; Nagata, K.; Hori, Y.; Yoshida, M.; Yokoyama, S.; Iwata, S.; Yokoyama, K., Crystal structure of A3B3 complex of V-ATPase from Thermus thermophilus. EMBO J., 2009, 28, (23), 3771-3779.
24. Wilkens, S.; Vasilyeva, E.; Forgac, M., Structure of the vacuolar ATPase by electron microscopy. J. Biol. Chem., 1999, 274, (45), 31804-31810.
25. +-ATPase plays a role in coupling of proton transport and ATP hydrolysis. J. Biol. Chem., 2000, 275, (29), 22075-22081.
26. Nishi, T.; Kawasaki-Nishi, S.; Forgac, M., Expression and function of the mouse V-ATPase d infunit isoforms. J. Biol. Chem., 2003, 278, (47), 46396-46402.
27. Noji, H.; Yasuda, R.; Yoshida, M.; Kinosita Jr., K., Direct observation of the rotation of F1-ATPase. Nature, 1997, 386, (6622), 299-302.
28. Sambongi, Y.; Iko, Y.; Tanabe, M.; Omote, H.; Iwamoto-Kihara, A.; Ueda, I.; Yanagida, T.; Wada, Y.; Futai, M., Mechanical rotation of the c infunit oligomer in ATP synthase (FOF1): Direct observation. Science, 1999, 286, (5445), 1722-1724.
29. +-ATPase. Novartis Found. Symp., 2002, 245, 207-222.
30. Diepholz, M.; Börsch, M.; Böttcher, B., Structural organization of the V-ATPase and its implications for regulatory assembly and disassembly. Biochem. Soc. Trans., 2008, 36, (5), 1027-1031.
31. Grüber, G.; Wieczorek, H.; Harvey, W.R.; Müller, V., Structure-function relationships of A-, F- and V-ATPases. J. Exp. Biol, 2001, 204, (15), 2597-2605.
32. Muench, S.P.; Huss, M.; Song, C.F.; Phillips, C; Wieczorek, H.; Trinick, J.; Harrison, M.A., Cryo-electron microscopy of the vacuolar ATPase motor reveals its mechanical and regulatory complexity. J. Mol. Biol., 2009, 386, (4), 989-999.
33. Lau, W.C.Y.; Rubinstein, J.L., Structure of intact Thermus thermophilus V-ATPase by cryo-EM reveals organization of the membrane-bound Vo motor. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, (4), 1367-1372.
34. Kawasaki-Nishi, S.; Nishi, T.; Forgac, M., Interacting helical surfaces of the transmembrane segments of infunits a and c' of the yeast V-ATPase defined by disulfide-mediated cross-linking. J. Biol. Chem., 2003, 278, (43), 41908-41913.
35. Wang, Y.; Inoue, T.; Forgac, M., TM2 but not TM4 of infunit c interacts with TM7 of infunit a of the yeast V-ATPase as defined by disulfide-mediated cross-linking. J. Biol. Chem., 2004, 279, (43), 44628-44638.
36. Kagawa, Y.; Hamamoto, T., The energy transmission in ATP synthase: From the rotor to the a3(33 oligomer fixed by OSCP-b stator via the pDELSEED sequence. J. Bioenerg. Biomembr., 1996, 28, (5), 421-431.
37. Forgac, M., Vacuolar ATPases: Rotary proton pumps in physiology and pathophysiology. Nat. Rev. Mol. Cell Biol, 2007, 8, (11), 917-929.
38. + extrusion. IEEE Trans. NanoBiosci., 2004, 3, (4), 257-264.
39. Landolt-Marticorena, C; Williams, K.M.; Correa, J.; Chen, W.; Manolson, M.F., Evidence that the NH2 terminus of Vph1p, an integral infunit of the V0 sector of the yeast V-ATPase, interacts directly with the Vma1p and Vma13p infunits of the V1 sector. J. Biol. Chem., 2000, 275, (20), 15449-15457.
40. Landolt-Marticorena, C; Kahr, W.H.; Zawarinski, P.; Correa, J.; Manolson, M.F., Infstrate- and inhibitor-induced conformational changes in the yeast V-ATPase provide evidence for communication between the catalytic and proton-translocating sectors. J. Biol. Chem., 1999, 274, (37), 26057-26064.
41. Kawasaki-Nishi, S.; Nishi, T.; Forgac, M., Yeast V-ATPase complexes containing different isoforms of the 100-kDa a-infunit differ in coupling efficiency and in vivo dissociation. J. Biol. Chem., 2001, 276, (21), 17941-17948.
42. Kawasaki-Nishi, S.; Nishi, T.; Forgac, M., Arg-735 of the 100-kDa infunit a of the yeast V-ATPase is essential for proton translocation. Proc. Natl. Acad. Sci. U. S. A., 2001, 98, (22), 12397-12402.
43. Maranda, B.; Brown, D.; Bourgoin, S.; Casanova, J.E.; Vinay, P.; Ausiello, D.A.; Marshansky, V., Intra-endosomal pH-sensitive recruitment of the Arf-nucleotide exchange factor ARNO and Arf6 from cytoplasm to proximal tubule endosomes. J. Biol Chem., 2001, 276, (21), 18540-18550.
44. Moriyama, Y.; Nelson, N., Cold inactivation of vacuolar proton-ATPases. J. Biol Chem., 1989, 264, (6), 3577-3582.
45. Wilkens, S.; Forgac, M., Three-dimensional structure of the vacuolar ATPase proton channel by electron microscopy. J. Biol Chem., 2001, 276, (47), 44064-44068.
46. +-ATPase infunit Vph1p. J. Biol Chem., 1994, 269, (19), 14064-14074.
47. Kawasaki-Nishi, S.; Bowers, K.; Nishi, T.; Forgac, M.; Stevens, T.H., The amino-terminal domain of the vacuolar proton-translocating ATPase a infunit controls targeting and in vivo dissociation, and the carboxyl-terminal domain affects coupling of proton transport and ATP hydrolysis. J. Biol. Chem., 2001, 276, (50), 47411-47420.
48. Manolson, M.F.; Yu, H.; Chen, W.; Yao, Y.; Li, K.; Lees, R.L.; Heersche, J.N.M., The a3 isoform of the 100-kDa V-ATPase infunit is highly but differentially expressed in large (≥10 nuclei) and small (≤5 nuclei) osteoclasts. J. Biol. Chem., 2003, 278, (49), 49271-49278.
49. Lee, S.-H.; Rho, J.; Jeong, D.; Sul, J.-Y.; Kim, T.; Kim, N.; Kang, J.-S.; Miyamoto, T.; Suda, T.; Lee, S.-K.; Pignolo, R.J.; Koczon-Jaremko, B.; Lorenzo, J.; Choi, Y., v-ATPase V0 infunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat. Med., 2006, 12, (12), 1403-1409.
50. Wu, H.; Xu, G.; Li, Y.-P., Atp6v0d2 Is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J. Bone Miner. Res., 2009, 24, (5), 871-885.
51. Inoue, T.; Forgac, M., Cysteine-mediated cross-linking indicates that infunit C of the V-ATPase is in close proximity to infunits E and G of the V1 domain and infunit a of the V0 domain. J. Biol. Chem., 2005, 280, (30), 27896-27903.
52. Qi, J.; Forgac, M., Function and infunit interactions of the N-terminal domain of infunit a (Vph1p) of the yeast V-ATPase. J. Biol. Chem., 2008, 283, (28), 19274-19282.
53. Hurtado-Lorenzo, A.; Skinner, M.; El Annan, J.; Futai, M.; Sun-Wada, G.-H.; Bourgoin, S.; Casanova, J.; Wildeman, A.; Bechoua, S.; Ausiello, D.A.; Brown, D.; Marshansky, V., V-ATPase interacts with ARNO and Arf6 in early endosomes and regulates the protein degradative pathway. Nat. Cell Biol, 2006, 8, (2), 124-136.
54. Merkulova, M.; Bakulina, A.; Thaker, Y.R.; Grüber, G.; Marshansky, V., Specific motifs of the V-ATPase a2-infunit isoform interact with catalytic and regulatory domains of ARNO. Biochim. Biophys. Acta, 2010, 1797, (8), 1398-1409.
55. Hiesinger, P.R.; Fayyazuddin, A.; Mehta, S.Q.; Rosenmund, T.; Schulze, K.L.; Zhai, R.G.; Verstreken, P.; Cao, Y.; Zhou, Y.; Kunz, J.; Bellen, H.J., The v-ATPase V0 infunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell, 2005, 121, (4), 607-620.
56. +-ATPase to apical membrane of renal epithelial cells. Am. J. Physiol. Cell Physiol, 2005, 289, (3), C665-C672.
57. Liégeois, S.; Benedetto, A.; Michaux, G.; Belliard, G.; Labouesse, M., Genes required for osmoregulation and apical secretion in Caenorhabditis elegans. Genetics, 2007, 175, 709-724.
58. +-ATPase exocytosis. J. Biol. Chem., 2003, 278, (22), 19791-19797.
59. +-ATPase. J. Biol. Chem., 2004, 279, (10), 8732-8739.
60. +-ATPase. Microbiol. Mol. Biol. Rev., 2006, 70, (1), 177-191.
61. Sun-Wada, G.-H.; Wada, Y.; Futai, M., Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: Toward the physiological understanding of inside acidic compartments. Biochim. Biophys. Acta, 2004, 1658, (1-2), 106-114.
62. Nordström, T.; Rotstein, O.D.; Romanek, R.; Asotra, S.; Heersche, J.N.M.; Manolson, M.F.; Brisseau, G.F.; Grinstein, S., Regulation of cytoplasmic pH in osteoclasts: Contribution of proton pumps and a proton-selective conductance. J. Biol. Chem., 1995, 270, (5), 2203-2212.
63. Schewe, B.; Schmälzlin, E.; Walz, B., Intracellular pH homeostasis and serotonin-induced pH changes in Calliphora salivary glands: The contribution of V-ATPase and carbonic anhydrase. J. Exp. Biol, 2008, 211, (5), 805-815.
64. Brown, D.; Paunescu, T.G.; Breton, S.; Marshansky, V., Regulation of the V-ATPase in kidney epithelial cells: Dual role in acid-base homeostasis and vesicle trafficking. J. Exp. Biol, 2009, 212, (11), 1762-1772.
65. Hinton, A.; Sennoune, S.R.; Bond, S.; Fang, M.; Reuveni, M.; Sahagian, G.G.; Jay, D.; Martinez-Zaguilan, R.; Forgac, M., Function of a infunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells. J. Biol. Chem., 2009, 284, (24), 16400-16408.
66. Brown, D.; Smith, P.J.S.; Breton, S., Role of V-ATPase-rich cells in acidification of the male reproductive tract. J. Exp. Biol, 1997, 200, (2), 257-262.
67. Henriksen, K.; Sørensen, M.G.; Jensen, V.K.; Dziegiel, M.H.; Nosjean, O.; Karsdal, M.A., Ion transporters involved in acidification of the resorption lacuna in osteoclasts. Calcif. Tissue Int., 2008, 83, 230-242.
68. Bartkiewicz, M.; Hernando, N.; Reddy, S.V.; Roodman, G.D.R.; Baron, R., Characterization of the osteoclast vacuolar H(+)-ATPase B-infunit. Gene, 1995, 160, (2), 157-164.
69. +-ATPase with the a3 isoform during osteoclast differentiation. J. Biol. Chem., 2003, 278, (24), 22023-22030.
70. Nishi, T.; Forgac, M., Molecular cloning and expression of three isoforms of the 100-kDa a infunit of the mouse vacuolar proton-translocating ATPase. J. Biol. Chem., 2000, 275, (10), 6824-6830.
71. +-ATPase: Preferential expression of the a 3 isoform during osteoclast differentiation. J. Biol. Chem., 2000, 275, (12), 8760-8765.
72. +-ATPase in microglia by RANKL. Biochem. Biophys. Res. Commun., 2009, 389, (1), 193-197.
73. Sun-Wada, G.-H.; Toyomura, T.; Murata, Y.; Yamamoto, A.; Futai, M.; Wada, Y., The a 3 isoform of V-ATPase regulates insulin secretion from pancreatic 3-cells. J. Cell Sci., 2006, 119, (21), 4531-4540.
74. Schinke, T.; Schilling, A.F.; Baranowsky, A.; Seitz, S.; Marshall, R.P.; Linn, T.; Blaeker, M.; Huebner, A.K.; Schulz, A.; Simon, R.; Gebauer, M.; Priemel, M.; Kornak, U.; Perkovic, S.; Barvencik, F.; Beil, F.T.; Del Flattorre, A.; Frattini, A.; Streichert, T.; Pueschel, K.; Villa, A.; Debatin, K.-M.; Rueger, J.M.; Teti, A.; Zustin, J.; Sauter, G.; Amling, M., Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat. Med., 2009, 15, (6), 674-682.
75. Feng, H.; Cheng, T.; Pavlos, N.J.; Yip, K.H.M.; Carrello, A.; Seeber, R.; Eidne, K.; Zheng, M.H.; Xu, J., Cytoplasmic terminus of vacuolar type proton pump accessory infunit Ac45 is required for proper interaction with V0 domain infunits and efficient osteoclastic bone resorption. J. Biol. Chem., 2008, 283, (19), 13194-13204.
76. +-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet., 2000, 9, (13), 2059-2063.
77. Frattini, A.; Orchard, P.J.; Sobacchi, C; Giliani, S.; Abinun, M.; Mattsson, J.P.; Keeling, D.J.; Andersson, A.K.; Wallbrandt, P.; Zecca, L.; Notarangelo, L.D.; Vezzoni, P.; Villa, A., Defects in TCIRG1 infunit of the vacuolar proton pump are responsible for a infset of human autosomal recessive osteopetrosis. Nat. Genet., 2000, 25, (3), 343-346.
78. Sobacchi, C; Frattini, A.; Orchard, P.; Porras, O.; Tezcan, I.; Andolina, M.; Babul-Hirji, R.; Baric, I.; Canham, N.; Chitayat, D.; Dupuis-Girod, S.; Ellis, I.; Etzioni, A.; Fasth, A.; Fisher, A.; Gerritsen, B.; Gulino, V.; Horwitz, E.; Klamroth, V.; Lanino, E.; Mirolo, M.; Musio, A.; Matthijs, G.; Nonomaya, S.; Notarangelo, L.D.; Ochs, H.D.; Superti Furga, A.; Valiaho, J.; van Hove, J.L.K.; Vihinen, M.; Vujic, D.; Vezzoni, P.; Villa, A., The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet., 2001, 10, (17), 1767-1773.
79. Scimeca, J.-C; Quincey, D.; Parrinello, H.; Romatet, D.; Grosgeorge, J.; Gaudray, P.; Philip, N.; Fischer, A.; Carle, G.F., Novel mutations in the TCIRG1 gene encoding the a3 infunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum. Mutat., 2003, 21, (2), 151-157.
80. Susani, L; Pangrazio, A.; Sobacchi, C; Taranta, A.; Mortier, G.; Savarirayan, R.; Villa, A.; Orchard, P.; Vezzoni, P.; Albertini, A.; Frattini, A.; Pagani, F., TCIRG1 -dependent recessive osteopetrosis: Mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum. Mutat, 2004, 24, (3), 225-235.
81. Li, Y.-P.; Chen, W.; Liang, Y.; Li, E.; Stashenko, P., Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet, 1999, 23, 447-451.
82. Scimeca, J.-C.; Franchi, A.; Trojani, C.; Parrinello, H.; Grosgeorge, J.; Robert, C.; Jaillon, O.; Poirier, C.; Gaudray, P.; Carle, G.F., The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase infunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone, 2000, 26, (3), 207-213.
83. Schumacher, K., Endomembrane proton pumps: connecting membrane and vesicle transport. Curr. Opin. Plant Biol., 2006, 9, (6), 595-600.
84. +-ATPase prevent segregation of lysosomal- and secretory-pathway proteins. J. Cell Sci., 2009, 122, (19), 3542-3553.
85. +ATPase a infunit to nerve terminals where it associates with both synaptic vesicles and the presynaptic plasma membrane. J. Cell Sci., 2003, 116, (23), 4751-4762.
86. Peters, C.; Bayer, M.J.; Bühler, S.; Andersen, J.S.; Mann, M.; Mayer, A., Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature, 2001, 409, (6820), 581-588.
87. +-ATPase infunit ATP6V0A2. Nat. Genet., 2008, 40, (1), 32-34.
88. Alper, S.L., Genetic diseases of acid-base transporters. Annu. Rev. Physiol., 2002, 64, 899-923.
89. +-ATPase infunit defective in an inherited form of distal renal tubular acidosis. J. Am. Soc. Nephrol., 2003, 14, (12), 3027-3038.
90. Stover, E.H.; Borthwick, K.J.; Bavalia, C.; Eady, N.; Fritz, D.M.; Rungroj, N.; Giersch, A.B.; Morton, C.C.; Axon, P.R.; Akil, I.; Al-Sabban, E.A.; Baguley, D.M.; Bianca, S.; Bakkaloglu, A.; Bircan, Z.; Chauveau, D.; Clermont, M.J.; Guala, A.; Hulton, S.A.; Kroes, H.; Li Volti, G.; Mir, S.; Mocan, H.; Nayir, A.; Ozen, S.; Rodriguez Soriano, J.; Sanjad, S.A.; Tasic, V.; Taylor, C.M.; Topaloglu, R.; Smith, A.N.; Karet, F.E., Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal recessive distal renal tubular acidosis with new evidence for hearing loss. J. Med. Genet., 2002, 39, (11), 796-803.
91. Smith, A.N.; Skaug, J.; Choate, K.A.; Nayir, A.; Bakkaloglu, A.; Ozen, S.; Hulton, S.A.; Sanjad, S.A.; Al-Sabban, E.A.; Lifton, R.P.; Scherer, S.W.; Karet, F.E., Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD infunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat. Genet., 2000, 26, (1), 71-75.
92. Martinez-Zaguilan, R.; Lynch, R.M.; Martinez, G.M.; Gillies, R.J., Vacuolar-type H(+)-ATPases are functionally expressed in plasma membranes of human tumor cells. Am. J. Physiol. Cell Physiol., 1993, 265, (4), C1015-C1029.
93. +-ATPase in drug-resistant human breast carcinoma cell lines. Biochem. Pharmacol., 1999, 57, (9), 1037-1046.
94. Xu, J.; Cheng, T.; Feng, H.T.; Pavlos, N.J.; Zheng, M.H., Structure and function of V-ATPases in osteoclasts: Potential therapeutic targets for the treatment of osteolysis. Histol. Histopathol., 2007, 22, (4), 443-454.
95. Yuan, F.-L.; Li, X.; Lu, W.-G.; Li, C.-W.; Li, J.-P.; Wang, Y., The vacuolar ATPase in bone cells: A potential therapeutic target in osteoporosis. Mol. Biol. Rep., 2010, 37, (7), 3561-3566.
96. Spugnini, E.P.; Citro, G.; Fais, S., Proton pump inhibitors as anti vacuolar-ATPases drug: A novel anticancer strategy. J. Exp. Clin. Cancer Res., 2010, 29, 44.
97. +-ATPases as a new strategy against cancer. Cancer Res., 2007, 67, (22), 10627-10630.
98. Njus, D.; Radda, G.K., Bioenergetic process in chromaffin granules: A new perspective on some old problems. Biochim. Biophys. Acta, 1978, 463, (3-4), 219-244.
99. +-translocating adenosine triphosphatase in vacuolar membranes of Saccharomyces cerevisiae. J. Biol. Chem., 1981, 256, (21), 10859-10863.
100. Ohsumi, Y.; Anraku, Y., Active transport of basic amino acids driven by a proton motive force in vacuolar membrane vesicles of Saccharomyces cerevisiae. J. Biol. Chem., 1981, 256, (5), 2079-2082.
101. +-translocating ATPases: Advances using membrane vesicles. Annu. Rev. Plant Physiol, 1985, 36, 175-208.
102. 2+-adenosine triphosphatase from vacuolar membranes of Saccharomyces cerevisiae. J. Biol. Chem., 1985, 260, (2), 1090-1095.
103. +-ATPases from mithochondria, plasma membranes, and vacuoles of fungal cells. J. Membr. Biol., 1986, 94, 83-97.
104. + pumping into intracellular organelles. Annu. Rev. Physiol., 1986, 48, 403-413.
105. Xie, X.-S.; Stone, D.K., Isolation and reconstitution of the clathrin-coated vesicle proton translocating complex. J. Biol. Chem., 1986, 261, (6), 2492-2495.
106. Moriyama, Y.; Nelson, N., The purified ATPase from chromaffin granule membranes is an anion-dependent proton pump. J. Biol. Chem., 1987, 262, (19), 9175-9180.
107. +-ATPase. J. Biol. Chem., 1989, 264, (32), 19236-19244.
108. Mellman, I.; Fuchs, R.; Helenius, A., Acidification of the endocytic and exocytic pathways. Annu. Rev. Biochem., 1986, 55, 663-700.
109. Manolson, M.F.; Percy, J.M.; Apps, D.K.; Xie, X.S.; Stone, D.K.; Poole, R.J., Proceedings of the membrane protein symposium, 1987, ((Goheen, S.C., ed.) Bio-Rad, Richmond, CA), 427-434.
110. +-ATPase: Implications for the origin of eukaryotes. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, (17), 6661-6665.
111. +-ATPases: Immunological relationships of the nucleotide-binding infunits. Biochem. Cell Biol., 1989, 67, 306-310.
112. Denda, K.; Konishi, J.; Oshima, T; Date, T.; Yoshida, M., Molecular cloning of the (3-infunit of a possible non-FoF1 type ATP synthase from the acidothermophilic archaebacterium, Sulfolobus acidocaldarius. J. Biol. Chem., 1988, 263, (33), 17251-17254.
113. +-ATPase: Homology to the p-chain of FOF1-ATPases. J. Biol. Chem., 1988, 263, (19), 9102-9112.
114. Pedersen, P.L.; Carafoli, E., Ion motive ATPases. I. Ubiquity, properties, and significance to cell function. Trends Biochem. Sci., 1987, 12, 146-150.
115. Morré, D.J.; Liedtke, C; Brightman, A.O.; Scherer, G.F.E., Head and stalk structures of soybean vacuolar membranes. Planta, 1991, 184, (3), 343-349.
116. Preston, R.A.; Murphy, R.F.; Jones, E.W., Assay of vacuolar pH in yeast and identification of acidification-defective mutants. Proc. Natl. Acad. Sci. U. S. A., 1989, 86, (18), 7027-7031.
117. +-ATPase. J. Biol. Chem., 1992, 267, (20), 14294-14303.
118. Lee, C; Ghoshal, K.; Beaman, K.D., Cloning of a cDNA for a T cell produced molecule with a putative immune regulatory cycle. Mol. Immunol., 1990, 27, (11), 1137-1144.
119. Manolson, M.F.; Proteau, D.; Jones, E.W., Evidence for a conserved 95-120 kDa infunit associated with and essential for activity of V-ATPases. J. Exp. Biol., 1992, 172, (105), 105-112.
120. Li, Y.-P.; Chen, W.; Stashenko, P., Molecular cloning and characterization of a putative novel human osteoclast-specific 116-kDa vacuolar proton pump infunit. Biochem. Biophys. Res. Commun., 1996, 218, (3), 813-821.
121. +-ATPase infunit a. J. Biol. Chem., 2001, 276, (43), 40050-40054.
122. Wassmer, T.; Kissmehl, R.; Cohen, J.; Plattner, H., Seventeen a-infunit isoforms of Paramecium V-ATPase provide high specialization in location and function. Mol. Biol. Cell, 2006, 17, (2), 917-930.
123. Bowman, B.J.; Dschida, W.J.; Harris, T.; Bowman, E.J., The vacuolar ATPase of Neurospora crassa contains an F1-like structure. J. Biol. Chem., 1989, 264, (26), 15606-15612.
124. Bowman, B.J.; Dschida, W.J.; Bowman, E.J., Vacuolar ATPase of Neurospora crassa: Electron microscopy, gene characterization and gene inactivation/mutation. J. Exp. Biol, 1992, 172, (1), 57-66.
125. Boekema, E.J.; Ubbink-Kok, T.; Lolkema, J.S.; Brisson, A.; Konings, W.N., Visualization of a peripheral stalk in V-type ATPase: Evidence for the stator structure essential to rotational catalysis. Proc. Natl. Acad. Sci. USA., 1997, 94, (26), 14291-14293.
126. +)-ATPases. J. Biol. Chem., 1999, 274, (19), 12951-12954.
127. Margolles-Clark, E.; Tenney, K.; Bowman, E.J.; Bowman, B.J., The structure of the vacuolar ATPase in Neurospora crassa. J. Bioenerg. Biomembr., 1999, 31, (1), 29-37.
128. Bowman, E.J.; Graham, L.A.; Stevens, T.H.; Bowman, B.J., The bafilomycin/concanamycin binding site in infunit c of the V-ATPase from Neurospora crassa and Saccharomyces cerevisiae. J. Biol. Chem., 2004, 279, (32), 33131-33138.
129. Wang, Y.; Inoue, T.; Forgac, M., Infunit a of the yeast V-ATPase participates in binding of bafilomycin. J. Biol. Chem., 2005, 280, (49), 40481-40488.
130. +-ATPase in mutants lacking one infunit of the enzyme. J. Biol. Chem., 1993, 268, (22), 16845-16851.
131. +-ATPase activity in murine peritoneal macrophages. J. Biol. Chem., 1996, 271, (4), 2005-2011.
132. + ATPase activity in osteoclasts. J. Biol. Chem., 1997, 272, (10), 6354-6360.
133. +-adenosine triphosphatase in a Japanese patient with infantile malignant osteopetrosis. Bone, 2002, 30, (2), 436-439.
134. deCarvalho, A.C.V.; Ndi, C.P.; Tsopmo, A.; Tane, P.; Ayafor, J.; Connolly, J.D.; Teem, J.L., A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTRAF508. Mol. Med., 2002, 8, (2), 75-87.
135. Raschke, W.C.; Baird, S.; Ralph, P.; Nakoinz, I., Functional macrophage cell lines transformed by Abelson leukemia virus. Cell, 1978, 15, (1), 261-267.
136. Hsu, H.; Lacey, D.L.; Dunstan, C.R.; Solovyev, I.; Colombero, A.; Timms, E.; Tan, H.-L.; Elliott, G.; Kelley, M.J.; Sarosi, I.; Wang, L.; Xia, X.-Z.; Elliott, R.; Chiu, L.; Black, T.; Scully, S.; Capparelli, C; Morony, S.; Shimamoto, G.; Bass, M.B.; Boyle, W.J., Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegrin ligand. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, (7), 3540-3545.
137. Collin-Osdoby, P.; Yu, X.; Zheng, H.; Osdoby, P., RANKL-mediated osteoclast formation from murine RAW 264.7 cells. Methods Mol. Med., 2003, 80, 153-166.
138. Fields, S.; Song, O.-k., A novel genetic system to detect protein-protein interactions. Nature, 1989, 340, (6230), 245-246.
139. Ma, J.; Ptashne, M., A new class of yeast transcriptional activators. Cell, 1987, 51, (1), 113-119.
140. +-ATPase intracellularly and on their plasma membranes. Am. J. Physiol. Cell Physiol., 1996, 270, (1), C382-C388.
141. Smith, D.B.; Johnson, K.S., Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene, 1988, 67, (1), 31-40.
142. LaVallie, E.R.; DiBlasio, E.A.; Kovacic, S.; Grant, K.L.; P.F., S.; McCoy, J.M., A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology, 1993, 11, (2), 187-193.
143. Heinemann, T.; Bulwin, G.-C.; Randall, J.; Schnieders, B.; Sandhoff, K.; Volk, H.-D.; Milford, E.; Gullans, S.R.; Utku, N., Genomic organization of the gene coding for TIRC7, a novel membrane protein essential for T cell activation. Genomics, 1999, 57, (3), 398-406.
144. +-ATPase contains a filamentous actin binding site. J. Biol. Chem., 2000, 275, (41), 32331-32337.
145. Carmichael, J.; DeGraff, W.G.; Gazdar, A.F.; Minna, J.D.; Mitchell, J.B., Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of chemosensitivity testing. Cancer Res., 1987, 47, (4), 936-942.
146. Martin, J.T.; Gooi, J.H.; Sims, N.A., Molecular mechanisms in coupling of bone formation to resorption. Crit. Rev. Eukaryot. Gene Expr., 2009, 19, (1), 73-88.
147. Pierroz, D.D.; Bonnet, N.; Baldock, P.A.; Ominsky, M.S.; Stolina, M.; Kostenuik, P.J.; Ferrari, S.L., Are osteoclasts needed for the bone anabolic response to parathyroid hormone? J. Biol. Chem., 2010, 285, 28164-28173.
148. Black, D.M.; Greenspan, S.L.; Ensrud, K.E.; Palermo, L.; McGowan, J.A.; Lang, T.F.; Garnero, P.; Bouxsein, M.L.; Bilezikian, J.P.; Rosen, C.J.; (for the PaTH Study Investigators), The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. New Engl. J. Med., 2003, 349, (13), 1207-1215.
149. Ettinger, B.; San Martin, J.; Crans, G.; Pavo, I., Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. J. Bone Miner. Res., 2004, 19, (5), 745-751.
150. Finkelstein, J.S.; Hayes, A.; Hunzelman, J.L.; Wyland, J.J.; Lee, H.; Neer, R.M., The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. New Engl. J. Med., 2003, 349, (13), 1216-1226.
151. Hodsman, A.B.; Bauer, D.C.; Dempster, D.W.; Dian, L.; Hanley, D.A.; Harris, S.T.; Kendler, D.L.; McClung, M.R.; Miller, P.D.; Olszynski, W.P.; Orwoll, E.; Yuen, C.K., Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr. Rev., 2005, 26, (5), 688-703.
152. Nyman, J.; Väänänen, H., A rationale for osteoclast selectivity of inhibiting the lysosomal V-ATPase a3 isoform. Calcif. Tissue Int., 2010, 87, (3), 273-283.